Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
Peter StachonKlaus KaierTimo HeidtWolfgang BotheAndreas ZirlikManfred ZehenderChristoph BodeConstantin von Zur MühlenPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
TAVR is off-label used in AR in clinical practice. TAVR seems to be a safe option for AR with regard to in-hospital outcomes. However, further research evaluating long-term outcomes is required to establish the feasibility of TAVR in pure AR.
Keyphrases
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- left ventricular
- clinical practice
- healthcare
- coronary artery disease
- cross sectional
- insulin resistance
- type diabetes
- acute care
- glycemic control
- adipose tissue
- adverse drug